Oral genomeA leader in oral and system health innovation and known for its rapid oral healthy saliva tests, he was named a prestigious finalist 2025 Pepperdine Graziadio's most funded company competition. Among more than 2,300 early-stage startups from across the United States, the oral genome is one of the top 26 companies that their market opportunities, innovation and leadership abilities are available.
Pepperdine's most funded company program has been in its 8th year, identifying startups with outstanding hope and investor-ready. Finalists are selected based on a rigorous assessment of financial forecasts, intellectual property, competitive advantage and management expertise.
“This recognition affirms the mission of the oral genome so that preventive oral and whole body health testing can be used by all,” said Dr. Tina Saw, CEO of Oral Genome. “By leveraging cutting-edge technology, we are shaping the future of medicine, not only innovative, but inclusive and practical for patients and providers.”
Oral Genome Rapid Health Saliva Tests can provide actionable oral health insights in just 15 minutes, enabling individuals and healthcare providers to take positive steps toward better overall health.
A complete list of winners and finalists can be found in Pepperdine Graziadio's The most funded company 2025 display cabinet.
About oral genome
Oral Genome is a pioneer in a health technology company based on saliva-based oral and systemic health testing. Its mission is to improve preventive care by performing fast, accessible and impactful testing for everyone.
Data connectiona computing database using AI is designed to simplify data management and accelerate research in neuroscience, oncology, and systems biology. It raised $4.9 million in seed funding round. Nina Capital is headquartered in Barcelona and Inoca Capital Partners in Salt Lake City, Austin-based Capital Factory led the round. Existing investors also participated in the seed round.
The company also recently joined the ninth group of Pharmstars for the global accelerator of a drug-centric digital health startup.
According to the press release, the new funding will help Data Connect expand its operations, enhance its proprietary SaaS platform, and expand its market reach to commercial life sciences and pharmaceutical companies in the United States and Europe.
To learn more, Click here.
Rhode Island Governor Dan McKee and Rhode Island Life Science Hub emission Ocean State LaboratoryAccording to the press release, the state’s first life science incubator to support and accelerate innovation companies’ growth in the life sciences field. The incubator will act as a hub for entrepreneurs, researchers and investors, providing the infrastructure and communities needed to transform breakthrough ideas into transformative solutions. Portal innovationis a risk development company specializing in the cultivation of early stage companies and will manage the Marine National Laboratory. The incubator is scheduled to open in Providence in partnership with Brown University next year and will offer 30,000 square feet of office and lab space and have up to 30 startups.
Members include:
- Mindimmune Therapeutics is a biopharmaceutical company focusing on neuroinflammation and Alzheimer's disease.
- MedTech Oncolux Inc. has developed advanced optical imaging and AI technologies to improve surgical procedures in the field of oncology.
- p53 therapeutic agent, pursuing a new class of small molecule therapies, aiming to overcome p53 tumor suppressor mutations in cancer.
- PAX therapy, advancing gene delivery technology to optimize the healing of tendon and ligament injuries.
- XM therapy, develops tissue repair and regeneration platforms for chronic diseases.
To learn more, click here.
Health channel Members of its 13th queue were recently announced. They include:
PrecisionHealth TPA (Frisco, Texas): Led by Craig Herndon, the company reinvents self-funded healthcare through technology-driven operations, transparent pricing and scalable recurring revenue.
Yu.sh (Milan, Italy | Dubai, UAE): Founded by Pietro Allegretti, Yu.sh combines fashion and wellness technologies with luxury heels equipped with smart insoles to enhance health through electrostatic stimulation.
Vaccinity, Inc. (Fort Worth, Texas): The vaccine company founded by Paul Evans is building an AI-powered clinical trial match to expand access and interests in distributed patient EHR.
Latica Med Ltd. (Ra'anana, Israel): Eduard Papirov pioneered non-invasive acoustic technology that aims to improve fertility by enhancing endometrial reception and healing.
Pumpinheart Limited (Galway, Ireland): Founded by Donald Hickey, PumpinHeart is developing a transcatheter implantable pump for advanced heart failure and retaining ejection fraction (HFPEF) to meet unmet needs that affect millions.
Near Wave (Austin, Texas): Founded by Roy Stillwell, near waves create an optical imaging system that helps doctors noninvasively determine the best treatments for breast cancer patients within a week.
Pollen Sense (Salt Lake City, Utah): Pollen Sense, co-founded by Kris Klein and David Noel, provides real-time high-resolution aerial particle insights through a deep technology platform and transformative applications in health, research and industries.
Self-service technology (Galway, Ireland): Founded by David Townley, SelfSense has developed an AI-powered Smartsplint that monitors occlusivity in real time to prevent dental implant failure and optimize treatment outcomes.
Harmoniq Biosciences Inc. (Austin, Texas): Founded by Mario Sierra, Harmoniq pioneered the world’s first continuous hormone monitoring (CHM) platform (“Galactone of hormones)” to provide real-time hormone data and AI-driven insights that transform fertility, menopause care, menopause management, testosterone optimization and endocrine research.
Sequest Bio (Boston, MA):Sequest Bio, founded by Ashkan Novin, uses biopsy, RNA sequencing and real-time metastasis assays to generate predictive models to provide oncologists with early, more accurate insights into how cancer develops.
Powerpect (Dallas, Texas): Led by Avinash Srinivasan, Powerpect is a sanitary technology company that has developed smart insoles that provide real-time insights to help prevent injuries and speed recovery.
photo: Urupong, Getty Images
